Scientists develop method to examine HIV drugs' structure

01/31/2010 | Reuters

A team of U.S. and British researchers created a crystal to further examine the 3-D structure of HIV drugs from Merck & Co. and Gilead Sciences and how they bind to and inhibit the integrase enzyme. The crystal, which was grown from an integrase found in a retrovirus similar to HIV, could help improve HIV medicines and prevent drug resistance, according to the study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT